Splenic Marginal Zone Lymphoma — Trials

Splenic Marginal Zone Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

135 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 9%
Top sponsor: City of Hope Medical Center
Termination share: 38.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 101–135 of 135 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00290472	CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia	completed	Phase 2	89	National Cancer Institute (NCI)NIH	1	May 23, 2014	clinicaltrials
NCT01231919	MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia	completed	Phase 1	45	National Cancer Institute (NCI)NIH	2	Apr 29, 2014	clinicaltrials